INDEPENDENT THINKING. TRACEABLE EVIDENCE.Research edition · 29 October 2026
Modern DosingTHE PRACTITIONER’S PERSPECTIVEA clearer view of
the peptide economy ↗
The provider file / Dossier 241
RESEARCH DOSSIER / NOT AN ENDORSEMENT

The Wellness Company

A dated business research record, with the original field-level evidence labels kept intact.

Source snapshot: 2026-10-29. “Verified” below is the source dataset author’s label—not an independent license, safety, quality or clinical audit by Modern Dosing. These pages are excluded from search indexing until reviewed.
Positioning & service claimsverified

Medical freedom, less insurance gatekeeping, integrated prescription/supplement care and needle-free weight-loss positioning. General emergency-kit messaging is outside the approved catalog scope.

Audienceread

Read: adults seeking cash-pay weight, metabolic and hormone care; testosterone and menopause programs have distinct male/female positioning. Political/health-freedom messaging is site positioning, not verified ad targeting.

Pricing & termssnapshot

Oral tirzepatide $349.99/30 days; men's hormone $449.99/90 days; women's $899.99/90 days. Membership $149.99/mo separately.

Clinical relationshipspartial

The Wellness Company Inc. is the platform. Still-published service terms, dated 21 June 2023 and checked 16 Oct 2026, say Authorized Providers contract through Locemtele P.C. and are independent, not TWC employees. Current program-specific state practice roster and actual patient assignment are not established. Named medical advisors do not prove employing-practice ownership.

Pharmacy & fulfillmentpartial

Current tirzepatide page says licensed 503A US compounding pharmacy, name on dispensing label, not named publicly. Older preferred-partner page names Partell Pharmacy; separate TWC Rx subscription page describes pharmacy services. Neither establishes actual GLP patient dispensing assignment. Current pharmacy page separately names Prescription Mart as an independent contracted pharmacy for the generic-discount program, explicitly not owned/affiliated. Not established as GLP compounder.

Advertising snapshotsnapshot

Google / Meta / LinkedIn public-library snapshots reviewed 16 Oct 2026. See channel observations, exact lookup links and creative caveats below.

Founding yearpartial

2022; launch announcement 14 Sep 2022.

Foundersverified

Foster Coulson, founder and chairman, per first-party leadership/annual letter. Complete co-founder roster not independently verified.

Location & entity contextpartial

Miami, Florida (company LinkedIn listing); legal incorporation and nationwide remote-care footprint are distinct.

Search visibility samplepartial

First-party catalog/terms and public search reviewed. Older indexed prices and similar company names can conflict; product tables retain those limits.

THE MODERN DOSING WEEKLY

The peptide news
that changes your week.

Evidence-backed developments. The moves that matter. What each means for your practice or business—in one weekly email.